Based on peripheral blood proteomic profiling data of IPF biomarkers in the multicenter IPF-PRO Registry, circulating levels of CCL17 and CCL22 are higher in the IPF patients than in controls [71]. The gene discussed is CCL22; the disease is idiopathic interstitial pneumonia.